SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15506603
Source:
http://linkedlifedata.com/resource/pubmed/id/15506603
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0017601
,
umls-concept:C0021888
,
umls-concept:C0030705
,
umls-concept:C0034380
,
umls-concept:C0036043
,
umls-concept:C0087111
,
umls-concept:C0090306
,
umls-concept:C2825951
pubmed:issue
5
pubmed:dateCreated
2004-10-27
pubmed:abstractText
To evaluate efficacy, safety and quality of life in ocular hypertensive or open-angle glaucoma patients changed to latanoprost from previous therapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9110772
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Ophthalmic Solutions
,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins F, Synthetic
,
http://linkedlifedata.com/resource/pubmed/chemical/latanoprost
pubmed:status
MEDLINE
pubmed:issn
1120-6721
pubmed:author
pubmed-author:FuchsMM
,
pubmed-author:HaverkampFF
,
pubmed-author:StewartW CWC
,
pubmed-author:WuenschSS
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
407-15
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15506603-Adrenergic beta-Antagonists
,
pubmed-meshheading:15506603-Antihypertensive Agents
,
pubmed-meshheading:15506603-Cross-Over Studies
,
pubmed-meshheading:15506603-Drug Therapy, Combination
,
pubmed-meshheading:15506603-Female
,
pubmed-meshheading:15506603-Glaucoma, Open-Angle
,
pubmed-meshheading:15506603-Humans
,
pubmed-meshheading:15506603-Intraocular Pressure
,
pubmed-meshheading:15506603-Male
,
pubmed-meshheading:15506603-Middle Aged
,
pubmed-meshheading:15506603-Ocular Hypertension
,
pubmed-meshheading:15506603-Ophthalmic Solutions
,
pubmed-meshheading:15506603-Prospective Studies
,
pubmed-meshheading:15506603-Prostaglandins F, Synthetic
,
pubmed-meshheading:15506603-Quality of Life
,
pubmed-meshheading:15506603-Questionnaires
,
pubmed-meshheading:15506603-Safety
pubmed:articleTitle
Intraocular pressure, safety and quality of life in glaucoma patients switching to latanoprost from adjunctive and monotherapy treatments.
pubmed:affiliation
Children Hospital at the University of Bonn, Bonn.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Controlled Clinical Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study